Metraipolis › archive › dc_f0fc4fe43bb0

Ablative radiotherapy in castration-resistant prostate cancer — Europe PMC PMID:42389925

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42389925
DOI
10.1111/bju.70368
License (as archived)
solo-consultazione
Archived
2026-10-18T12:02:25.746Z
SHA-256 of the archived text
876d98daead6e8670a1ecc3edc457f8b6fa3a732e63e2a8304f92627fce6e34a
Stable URL of this page
https://metraipolis.com/documento/dc_f0fc4fe43bb0

How to cite

Ablative radiotherapy in castration-resistant prostate cancer — Europe PMC PMID:42389925 — Europe PMC (en), https://europepmc.org/article/MED/42389925 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0fc4fe43bb0 (Metraipolis archive dc_f0fc4fe43bb0, sha256 876d98daead6e8670a1ecc3edc457f8b6fa3a732e63e2a8304f92627fce6e34a)
BibTeX
@misc{dcf0fc4fe43bb0,
  title = {Ablative radiotherapy in castration-resistant prostate cancer — Europe PMC PMID:42389925},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42389925},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0fc4fe43bb0; sha256 876d98daead6e8670a1ecc3edc457f8b6fa3a732e63e2a8304f92627fce6e34a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42389925. Agents can read the archived copy with the MCP tool read_document.